Alpha Teknova Prices $40 Million Offering After 22.9% Share Drop

Alpha Teknova, Inc. priced eight million shares at $5 apiece, targeting $40 million in gross proceeds after an earlier after-hours quote put the stock down 22.9%.

At 7:58 p.m. ET (23:58 UTC) Oct. 20, shares were quoted at $5.70, 22.9% below the $7.39 regular-session close. Teknova announced final pricing at 10:30 p.m. ET Oct. 20 (02:30 UTC Oct. 21), so the quote preceded the announcement of the offering terms.

Underwriters may buy up to 1.2 million additional shares during a 30-day option period. The company expects the offering to close on or about Oct. 22, subject to customary conditions. Gross proceeds are before underwriting discounts, commissions and other expenses.

Teknova plans to use net proceeds for general corporate purposes, potentially including repayment of outstanding debt. The company produces critical reagents for life sciences applications such as therapies, vaccines and molecular diagnostics.

Teknova also estimated third-quarter revenue of $12.5 million to $12.7 million, gross margin of 36% to 38% and an adjusted EBITDA loss of $1 million to $1.2 million. The estimates put revenue 19% to 21% above the year-earlier period. The company estimated cash and short-term investments of $16.6 million as of Sept. 30.

The financial estimates are preliminary and unaudited, and remain subject to the company’s financial close and quarterly review.